Maximizing patient care and outcomes in knee arthroplasty prosthetic joint infection
Arthroscopy (with its role limited to the temporizing and/or stabilization of an acutely septic patient, with a possible role in diagnosis for organism identification through tissue specimen acquisition) DAIR, single stage revision, two stage revision, conservative management with long-term infectio...
Gespeichert in:
Veröffentlicht in: | The knee 2020-12, Vol.27 (6), p.A2-A3 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | A3 |
---|---|
container_issue | 6 |
container_start_page | A2 |
container_title | The knee |
container_volume | 27 |
creator | Lenard, Holly Brown |
description | Arthroscopy (with its role limited to the temporizing and/or stabilization of an acutely septic patient, with a possible role in diagnosis for organism identification through tissue specimen acquisition) DAIR, single stage revision, two stage revision, conservative management with long-term infection suppression (non-curative), and salvage procedures (including knee fusion and above knee amputation.) Early diagnosis and patient direction to the care of a MDT, also potentially allows for more diverse surgical intervention options, including DAIR, and single stage revision surgery. [5], in “Debridement, antibiotics and implant retention (DAIR) for the management of knee prosthetic joint infection,” notes that, “Although no strict time limits should be placed upon the decision to undertake DAIR in appropriate cases, infection that has been present for at least four to six weeks is more likely to have a mature biofilm that would be more difficult to eradicate without removal of all foreign material.” (Porteous [6]) Finally, in some instances, cure, “defined as freedom from clinical signs and symptoms of infection, normalised biochemical parameters (C-reactive protein (CRP), erythrocyte sedimentation rate (ESR)) and no further requirement for surgical intervention or antibiotic therapy at two years post-treatment,” (Kalson [1]) may not be possible. |
doi_str_mv | 10.1016/j.knee.2020.12.001 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2471538639</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S096801602030394X</els_id><sourcerecordid>2470611168</sourcerecordid><originalsourceid>FETCH-LOGICAL-c335t-a173a76f03bced446dcaebb02a4d282f59b653f49f213d8b9232c7a7caa87cc33</originalsourceid><addsrcrecordid>eNp9kMtKxDAUhoMoOl5ewIUE3LjpmEubtuBGBm-guNF1SNNTTZ0mY5KK-vSmjLpw4Spw-P4_53wIHVIyp4SK037-YgHmjLA0YHNC6Aaa0arkWVERsolmpBZVlkiyg3ZD6Akhos6LbbTDOc8prfkMPdypdzOYT2Of8EpFAzZirTxgZVvsxqjdAAEbi6evsPLx2bvVUoX4gVfehfgM0WjcO5Nyxnago3F2H211ahng4PvdQ4-XFw-L6-z2_upmcX6bac6LmClaclWKjvBGQ5vnotUKmoYwlbesYl1RN6LgXV53jPK2amrGmS5VqZWqSp069tDJujet8jpCiHIwQcNyqSy4MUiWl7TgleB1Qo__oL0bvU3bTRQRlFJRJYqtKZ1uCx46ufJmUP5DUiIn57KXkwg5OZeUyeQ8hY6-q8dmgPY38iM5AWdrAJKLNwNeBp1Ep5uNT8Jk68x__V-Ba5M2</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2470611168</pqid></control><display><type>article</type><title>Maximizing patient care and outcomes in knee arthroplasty prosthetic joint infection</title><source>Access via ScienceDirect (Elsevier)</source><creator>Lenard, Holly Brown</creator><contributor>Lenard, Holly Brown</contributor><creatorcontrib>Lenard, Holly Brown ; Lenard, Holly Brown</creatorcontrib><description>Arthroscopy (with its role limited to the temporizing and/or stabilization of an acutely septic patient, with a possible role in diagnosis for organism identification through tissue specimen acquisition) DAIR, single stage revision, two stage revision, conservative management with long-term infection suppression (non-curative), and salvage procedures (including knee fusion and above knee amputation.) Early diagnosis and patient direction to the care of a MDT, also potentially allows for more diverse surgical intervention options, including DAIR, and single stage revision surgery. [5], in “Debridement, antibiotics and implant retention (DAIR) for the management of knee prosthetic joint infection,” notes that, “Although no strict time limits should be placed upon the decision to undertake DAIR in appropriate cases, infection that has been present for at least four to six weeks is more likely to have a mature biofilm that would be more difficult to eradicate without removal of all foreign material.” (Porteous [6]) Finally, in some instances, cure, “defined as freedom from clinical signs and symptoms of infection, normalised biochemical parameters (C-reactive protein (CRP), erythrocyte sedimentation rate (ESR)) and no further requirement for surgical intervention or antibiotic therapy at two years post-treatment,” (Kalson [1]) may not be possible.</description><identifier>ISSN: 0968-0160</identifier><identifier>EISSN: 1873-5800</identifier><identifier>DOI: 10.1016/j.knee.2020.12.001</identifier><identifier>PMID: 33341193</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Amputation ; Antibiotics ; Arthroplasty (knee) ; Arthroscopy ; Biofilms ; C-reactive protein ; Debridement ; Diagnosis ; Erythrocyte sedimentation rate ; Infections ; Joint diseases ; Joint replacement surgery ; Joint surgery ; Medical referrals ; Patients ; Prostheses ; Surgeons ; Surgery ; Transplants & implants</subject><ispartof>The knee, 2020-12, Vol.27 (6), p.A2-A3</ispartof><rights>2020</rights><rights>Copyright Elsevier Limited Dec 2020</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c335t-a173a76f03bced446dcaebb02a4d282f59b653f49f213d8b9232c7a7caa87cc33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.knee.2020.12.001$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33341193$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Lenard, Holly Brown</contributor><creatorcontrib>Lenard, Holly Brown</creatorcontrib><title>Maximizing patient care and outcomes in knee arthroplasty prosthetic joint infection</title><title>The knee</title><addtitle>Knee</addtitle><description>Arthroscopy (with its role limited to the temporizing and/or stabilization of an acutely septic patient, with a possible role in diagnosis for organism identification through tissue specimen acquisition) DAIR, single stage revision, two stage revision, conservative management with long-term infection suppression (non-curative), and salvage procedures (including knee fusion and above knee amputation.) Early diagnosis and patient direction to the care of a MDT, also potentially allows for more diverse surgical intervention options, including DAIR, and single stage revision surgery. [5], in “Debridement, antibiotics and implant retention (DAIR) for the management of knee prosthetic joint infection,” notes that, “Although no strict time limits should be placed upon the decision to undertake DAIR in appropriate cases, infection that has been present for at least four to six weeks is more likely to have a mature biofilm that would be more difficult to eradicate without removal of all foreign material.” (Porteous [6]) Finally, in some instances, cure, “defined as freedom from clinical signs and symptoms of infection, normalised biochemical parameters (C-reactive protein (CRP), erythrocyte sedimentation rate (ESR)) and no further requirement for surgical intervention or antibiotic therapy at two years post-treatment,” (Kalson [1]) may not be possible.</description><subject>Amputation</subject><subject>Antibiotics</subject><subject>Arthroplasty (knee)</subject><subject>Arthroscopy</subject><subject>Biofilms</subject><subject>C-reactive protein</subject><subject>Debridement</subject><subject>Diagnosis</subject><subject>Erythrocyte sedimentation rate</subject><subject>Infections</subject><subject>Joint diseases</subject><subject>Joint replacement surgery</subject><subject>Joint surgery</subject><subject>Medical referrals</subject><subject>Patients</subject><subject>Prostheses</subject><subject>Surgeons</subject><subject>Surgery</subject><subject>Transplants & implants</subject><issn>0968-0160</issn><issn>1873-5800</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kMtKxDAUhoMoOl5ewIUE3LjpmEubtuBGBm-guNF1SNNTTZ0mY5KK-vSmjLpw4Spw-P4_53wIHVIyp4SK037-YgHmjLA0YHNC6Aaa0arkWVERsolmpBZVlkiyg3ZD6Akhos6LbbTDOc8prfkMPdypdzOYT2Of8EpFAzZirTxgZVvsxqjdAAEbi6evsPLx2bvVUoX4gVfehfgM0WjcO5Nyxnago3F2H211ahng4PvdQ4-XFw-L6-z2_upmcX6bac6LmClaclWKjvBGQ5vnotUKmoYwlbesYl1RN6LgXV53jPK2amrGmS5VqZWqSp069tDJujet8jpCiHIwQcNyqSy4MUiWl7TgleB1Qo__oL0bvU3bTRQRlFJRJYqtKZ1uCx46ufJmUP5DUiIn57KXkwg5OZeUyeQ8hY6-q8dmgPY38iM5AWdrAJKLNwNeBp1Ep5uNT8Jk68x__V-Ba5M2</recordid><startdate>202012</startdate><enddate>202012</enddate><creator>Lenard, Holly Brown</creator><general>Elsevier B.V</general><general>Elsevier Limited</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>202012</creationdate><title>Maximizing patient care and outcomes in knee arthroplasty prosthetic joint infection</title><author>Lenard, Holly Brown</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c335t-a173a76f03bced446dcaebb02a4d282f59b653f49f213d8b9232c7a7caa87cc33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Amputation</topic><topic>Antibiotics</topic><topic>Arthroplasty (knee)</topic><topic>Arthroscopy</topic><topic>Biofilms</topic><topic>C-reactive protein</topic><topic>Debridement</topic><topic>Diagnosis</topic><topic>Erythrocyte sedimentation rate</topic><topic>Infections</topic><topic>Joint diseases</topic><topic>Joint replacement surgery</topic><topic>Joint surgery</topic><topic>Medical referrals</topic><topic>Patients</topic><topic>Prostheses</topic><topic>Surgeons</topic><topic>Surgery</topic><topic>Transplants & implants</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lenard, Holly Brown</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>The knee</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lenard, Holly Brown</au><au>Lenard, Holly Brown</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Maximizing patient care and outcomes in knee arthroplasty prosthetic joint infection</atitle><jtitle>The knee</jtitle><addtitle>Knee</addtitle><date>2020-12</date><risdate>2020</risdate><volume>27</volume><issue>6</issue><spage>A2</spage><epage>A3</epage><pages>A2-A3</pages><issn>0968-0160</issn><eissn>1873-5800</eissn><abstract>Arthroscopy (with its role limited to the temporizing and/or stabilization of an acutely septic patient, with a possible role in diagnosis for organism identification through tissue specimen acquisition) DAIR, single stage revision, two stage revision, conservative management with long-term infection suppression (non-curative), and salvage procedures (including knee fusion and above knee amputation.) Early diagnosis and patient direction to the care of a MDT, also potentially allows for more diverse surgical intervention options, including DAIR, and single stage revision surgery. [5], in “Debridement, antibiotics and implant retention (DAIR) for the management of knee prosthetic joint infection,” notes that, “Although no strict time limits should be placed upon the decision to undertake DAIR in appropriate cases, infection that has been present for at least four to six weeks is more likely to have a mature biofilm that would be more difficult to eradicate without removal of all foreign material.” (Porteous [6]) Finally, in some instances, cure, “defined as freedom from clinical signs and symptoms of infection, normalised biochemical parameters (C-reactive protein (CRP), erythrocyte sedimentation rate (ESR)) and no further requirement for surgical intervention or antibiotic therapy at two years post-treatment,” (Kalson [1]) may not be possible.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>33341193</pmid><doi>10.1016/j.knee.2020.12.001</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0968-0160 |
ispartof | The knee, 2020-12, Vol.27 (6), p.A2-A3 |
issn | 0968-0160 1873-5800 |
language | eng |
recordid | cdi_proquest_miscellaneous_2471538639 |
source | Access via ScienceDirect (Elsevier) |
subjects | Amputation Antibiotics Arthroplasty (knee) Arthroscopy Biofilms C-reactive protein Debridement Diagnosis Erythrocyte sedimentation rate Infections Joint diseases Joint replacement surgery Joint surgery Medical referrals Patients Prostheses Surgeons Surgery Transplants & implants |
title | Maximizing patient care and outcomes in knee arthroplasty prosthetic joint infection |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T00%3A02%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Maximizing%20patient%20care%20and%20outcomes%20in%20knee%20arthroplasty%20prosthetic%20joint%20infection&rft.jtitle=The%20knee&rft.au=Lenard,%20Holly%20Brown&rft.date=2020-12&rft.volume=27&rft.issue=6&rft.spage=A2&rft.epage=A3&rft.pages=A2-A3&rft.issn=0968-0160&rft.eissn=1873-5800&rft_id=info:doi/10.1016/j.knee.2020.12.001&rft_dat=%3Cproquest_cross%3E2470611168%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2470611168&rft_id=info:pmid/33341193&rft_els_id=S096801602030394X&rfr_iscdi=true |